XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net loss $ (13,558) $ (1,710) $ 1,241
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 5,197 3,248 2,845
Reduction of operating lease right-of-use assets 741 1,311 1,192
Loss on impairment, receivables and sale or disposal of equipment 319 162 60
Stock-based compensation 14,574 17,837 1,706
Amortization of debt issuance costs 32 32 32
Deferred tax assets 48 2,437 (2,855)
Deferred tax liabilities (916) 916 0
Changes in assets and liabilities:      
Accounts receivable (6,006) (2,170) (1,955)
Settlement assets 173 2,878 1,599
Prepaid expenses (6,509) 270 3,628
Other current assets (4,100) (1,393) 45
Related party loan receivable 586 0 0
Other assets 124 (248) (31)
Accounts payable 1,424 (714) 446
Accrued expenses and other liabilities 7,511 1,774 226
Operating lease liabilities (801) (1,374) (1,252)
Settlement liabilities 7,372 (16,548) 5,503
Other liabilities (725) 877 0
Net cash provided by operating activities 5,486 7,585 12,430
Cash flows from investing activities:      
Purchase of property and equipment (2,706) (2,488) (3,235)
Proceeds from sale or disposal of property and equipment 0 2 4
Software development costs (4,908) (1,809) (1,673)
Net cash used by investing activities (7,614) (4,295) (4,904)
Cash flows from financing activities:      
Principal payments of finance leases (774) (808) (793)
Principal payments of term loan (25,191) (319) (39)
Proceeds from term loan 45,000 0 0
Principal payments of line of credit 0 (1,000) 0
Proceeds from line of credit 0 9,613 5,500
Repurchases of common stock 0 0 (14)
Vesting of restricted common stock 567 0 0
Proceeds from initial public offering, net of underwriters' discounts and commissions 57,458 0 0
Proceeds from issuance of common stock on exercise of stock options 3,505 1,301 482
Net cash provided by financing activities 80,565 8,787 5,136
Net increase in cash and cash equivalents 78,437 12,077 12,662
Cash and cash equivalents and restricted cash, beginning of period 46,878 34,801 22,139
Cash and cash equivalents and restricted cash, end of period 125,315 46,878 34,801
Supplemental disclosure of cash flow information:      
Cash paid for interest 3,082 2,929 2,708
Cash paid for income taxes 6,922 150 216
Noncash investing and financing items:      
Commercial building and land acquired with long-term debt (net of issuance costs of $8,226) 0 0 10,644
Right-of-use assets acquired with lease liabilities 0 1,260 1,210
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets      
Cash and cash equivalents 98,398 34,401 9,990
Restricted cash included in other current assets 8,651 1,955 421
Restricted cash included in other assets 47 48 246
Restricted cash included in settlement assets 18,219 10,474 24,144
Total cash, cash equivalents and restricted cash $ 125,315 $ 46,878 $ 34,801